Prostaglandin based compositions and method of use thereof
A prostaglandin and composition technology, which can be used in pharmaceutical formulations, cosmetic preparations, cosmetic preparations and other directions, and can solve problems such as damage to efficacy and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0091] Example 1. Pre-blended compositions
[0092]
[0093] List of pre-blended ingredients:
[0094] Cetiol AB (including C12-15 alkyl benzoate) may be present in appropriate amounts (QS).
[0095] Prostaglandin E 2 The content of its derivatives may be in the range of about 0.001% or less to about 15% or more, such as about 0.01% to about 12%, including about 0.1% to about 10%, such as about 1% to about 5%, Including about 4-4.5%.
[0096] The content of SDA 40B (e.g., ethanol) may range from about 0.001% or less to about 15% or more, such as from about 0.01% to about 10%, including from about 0.1% to about 9%, such as from about 1% to about 8% %. The blend can then be mixed in the final formulation, for example at about 0.34%.
[0097] Exemplary methods of preparing premixes:
[0098] 1. In a small container, weigh the prostaglandin type compound of the present invention.
[0099] 2. Add ethanol.
[0100] 3. Add the C12-15 Alkyl Benzoate and mix for 10 minutes, ...
Embodiment 2
[0102] Example 2. Direct Blend Compositions
[0103]
[0104] Direct Blend Ingredients List:
[0105] In certain embodiments, prostaglandin E 2 The content of its derivatives may be in the range of about 0.001% or less to about 15% or more, such as about 0.01% to about 12%, including about 0.1% to about 10%, such as about 1% to about 5%, Including about 4-4.5%. The direct blend can be mixed, eg, at about 0.30%, directly into the final formulation, eg, without prior blending with the C12-15 alkyl benzoate and / or ethanol.
[0106] Exemplary methods of preparing premixes:
[0107] 1. In a small container, weigh the prostaglandin type compound of the present invention.
[0108] 2. Add directly to eyelash shine improving composition.
Embodiment 3
[0109] Example 3. Eyelash Shine Improvement Composition
[0110]
[0111]
[0112] Exemplary methods of making eyelash shine improving compositions:
[0113] 1. Add Phase B to a small container.
[0114] 2. Add phase C.
[0115] 3. Add phase A and mix for about 10 minutes, the solution should be clear.
[0116] final recipe
[0117] A-water-appropriate amount
[0118] A-Cavamax-0-5%
[0119] A-Pemulen-0-1%
[0120] A-Panthenol - 0-1%
[0121] A-Ritaloe 200M-0-1%
[0122] B-AMS Leucidal Liquid - 0-2.5%
[0123] C-TEA 99%-0-1%
[0124] D-Liposome ACE-0-1%
[0125] D-Actiglide-0-20%
[0126] D-Lash Premix - 0-5%
[0127] Specifically, fill the mains with water and start propeller mixing. Sift each ingredient of Phase A and mix until completely dispersed. Switch to sweep mixing. Add phase B. Add phase C. And add phase D.
[0128] The final pH of the formulation can be adjusted to be in the range of about pH 5.0-6.5.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 